Subsense secures $27M in seed funding to develop non-surgical brain-computer interfaces using nasally delivered nanoparticles.
Amount Raised
$27 Million
Round Type
Seed
Marina Del ReyBiotechnologyHealth CareMedicalMedical DeviceDescription
Subsense, a Palo Alto-based neurotechnology startup, announced a $27M seed funding round to advance its NanoBCI platform. The technology uses intranasally delivered nanoparticles combined with a wearable headset to read neural signals and stimulate brain activity without surgery. The company's immediate clinical targets include Parkinson's disease and epilepsy, with plans to demonstrate nanoparticle-enabled neural reading and symptom relief by the end of 2026. Founded around 2021-2022 by Tetiana Aleksandrova and Artem Sokolov, Subsense represents a novel approach to brain-computer interfaces.
Who to call at Subsense, and when
A new round usually means Subsense is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Subsense raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Subsense, from your own LinkedIn network
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Subsense raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Subsense raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.